LSE:PRTC (PureTech Health plc)
About PRTC
PureTech Health is a hub-and-spoke biotherapeutics company dedicated to giving life to science and transforming innovation into value. We do this through a proven, capital-efficient R&D model focused on opportunities with validated pharmacology and untapped potential to address significant patient needs. This strategy has produced dozens of therapeutic candidates, including three that have received U.S. FDA approval. By identifying, shaping, and de-risking these high-conviction assets, and scaling them through dedicated structures backed by external capital, we accelerate their path to patients while creating sustainable value for shareholders.
PureTech Health plc (LSE: PRTC) Latest News
Investing Articles
3 UK shares tipped to more than DOUBLE my money in 2026!
Investing Articles
After hitting a five-year low I’m betting this hidden gem will rocket like the Rolls-Royce share price
Investing Articles
Here’s why I’d buy these FTSE 250 stocks near 52-week lows
Investing Articles
Are these 2 FTSE 250 shares now unmissable buys after crashing 48%?
Investing Articles
A FTSE 250 growth share I’d buy to target a multibagger return
Investing Articles
Here’s why these FTSE 250 shares could be set for explosive growth
Investing Articles
Here’s one FTSE 250 stock I’d buy in April
Investing Articles
2 impressive growth stocks I’ve got my eye on in February
Investing Articles
2 sizzling growth stocks that soared 12% to 31% higher in December
Investing Articles
Here’s why this could be one of the best UK growth stocks to buy right now
Investing Articles
3 shares to buy with £10,000 today
Page
Investing in Biotech: Top UK Biotech Stocks of 2026
1❯